These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

913 related articles for article (PubMed ID: 9755153)

  • 1. Potassium channel openers require ATP to bind to and act through sulfonylurea receptors.
    Schwanstecher M; Sieverding C; Dörschner H; Gross I; Aguilar-Bryan L; Schwanstecher C; Bryan J
    EMBO J; 1998 Oct; 17(19):5529-35. PubMed ID: 9755153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure.
    Dörschner H; Brekardin E; Uhde I; Schwanstecher C; Schwanstecher M
    Mol Pharmacol; 1999 Jun; 55(6):1060-6. PubMed ID: 10347249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
    Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
    Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP.
    Hambrock A; Löffler-Walz C; Kloor D; Delabar U; Horio Y; Kurachi Y; Quast U
    Mol Pharmacol; 1999 May; 55(5):832-40. PubMed ID: 10220561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential response of K(ATP) channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil.
    Reimann F; Gribble FM; Ashcroft FM
    Mol Pharmacol; 2000 Dec; 58(6):1318-25. PubMed ID: 11093769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
    Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
    Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Kir6.2-F333I mutation differentially modulates KATP channels composed of SUR1 or SUR2 subunits.
    Tammaro P; Ashcroft F
    J Physiol; 2007 Jun; 581(Pt 3):1259-69. PubMed ID: 17395632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR and fluorescence studies of drug binding to the first nucleotide binding domain of SUR2A.
    López-Alonso JP; de Araujo ED; Kanelis V
    Biochemistry; 2012 Nov; 51(45):9211-22. PubMed ID: 23078514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K(+) channels.
    Matsuoka T; Matsushita K; Katayama Y; Fujita A; Inageda K; Tanemoto M; Inanobe A; Yamashita S; Matsuzawa Y; Kurachi Y
    Circ Res; 2000 Nov; 87(10):873-80. PubMed ID: 11073882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
    Hambrock A; Löffler-Walz C; Russ U; Lange U; Quast U
    Mol Pharmacol; 2001 Jul; 60(1):190-9. PubMed ID: 11408614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mg2+ and ATP dependence of K(ATP) channel modulator binding to the recombinant sulphonylurea receptor, SUR2B.
    Hambrock A; Löffler-Walz C; Kurachi Y; Quast U
    Br J Pharmacol; 1998 Oct; 125(3):577-83. PubMed ID: 9806343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2B.
    Matsuo M; Tanabe K; Kioka N; Amachi T; Ueda K
    J Biol Chem; 2000 Sep; 275(37):28757-63. PubMed ID: 10893240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUR2 subtype (A and B)-dependent differential activation of the cloned ATP-sensitive K+ channels by pinacidil and nicorandil.
    Shindo T; Yamada M; Isomoto S; Horio Y; Kurachi Y
    Br J Pharmacol; 1998 Jul; 124(5):985-91. PubMed ID: 9692785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits.
    Löffler-Walz C; Hambrock A; Quast U
    Mol Pharmacol; 2002 Feb; 61(2):407-14. PubMed ID: 11809866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological comparison of native mitochondrial K(ATP) channels with molecularly defined surface K(ATP) channels.
    Liu Y; Ren G; O'Rourke B; Marbán E; Seharaseyon J
    Mol Pharmacol; 2001 Feb; 59(2):225-30. PubMed ID: 11160857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mutation Y1206S increases the affinity of the sulphonylurea receptor SUR2A for glibenclamide and enhances the effects of coexpression with Kir6.2.
    Stephan D; Stauss E; Lange U; Felsch H; Löffler-Walz C; Hambrock A; Russ U; Quast U
    Br J Pharmacol; 2005 Apr; 144(8):1078-88. PubMed ID: 15711591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression with the inward rectifier K(+) channel Kir6.1 increases the affinity of the vascular sulfonylurea receptor SUR2B for glibenclamide.
    Russ U; Hambrock A; Artunc F; Löffler-Walz C; Horio Y; Kurachi Y; Quast U
    Mol Pharmacol; 1999 Nov; 56(5):955-61. PubMed ID: 10531400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A view of sur/KIR6.X, KATP channels.
    Babenko AP; Aguilar-Bryan L; Bryan J
    Annu Rev Physiol; 1998; 60():667-87. PubMed ID: 9558481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of the Walker A lysine by arginine in the nucleotide-binding domains of sulphonylurea receptor SUR2B: effects on ligand binding and channel activity.
    Amann T; Schell S; Kühner P; Winkler M; Schwanstecher M; Russ U; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Jun; 381(6):507-16. PubMed ID: 20352196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and effect of K ATP channel openers in the absence of Mg2+.
    Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
    Br J Pharmacol; 2003 May; 139(2):368-80. PubMed ID: 12770942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.